Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Cross DM"'
Publikováno v:
Biochemical Society transactions. 18(6)
Publikováno v:
Journal of Nuclear Medicine Technology; Dec1998, Vol. 26 Issue 4, p265-268, 4p
Autor:
Mann A, Ahlberg AW, White MP, Cross DM, Piriz J, Morris RS, Heller GV, Mann, A, Ahlberg, A W, White, M P, Cross, D M, Piriz, J, Morris, R S, Heller, G V
Publikováno v:
Journal of Nuclear Medicine Technology; Sep1998, Vol. 26 Issue 3, p186-190, 5p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Journal of Nuclear Cardiology January-February 1997 4(1) Part 2:S1-S1
Autor:
Nathan PJ; Heptares Therapeutics Ltd Cambridge UK.; Department of Psychiatry University of Cambridge Cambridge UK., Millais SB; Heptares Therapeutics Ltd Cambridge UK., Godwood A; Heptares Therapeutics Ltd Cambridge UK., Dewit O; Heptares Therapeutics Ltd Cambridge UK., Cross DM; Cross Pharma Consulting Limited Cambridge UK., Liptrot J; Heptares Therapeutics Ltd Cambridge UK., Ruparelia B; Heptares Therapeutics Ltd Cambridge UK., Jones SP; tranScrip Partners LLP Wokingham UK., Bakker G; Heptares Therapeutics Ltd Cambridge UK., Maruff PT; Cogstate Ltd New Haven Connecticut USA., Light GA; Department of Psychiatry University of San Diego San Diego California USA., Brown AJH; Heptares Therapeutics Ltd Cambridge UK., Weir MP; Heptares Therapeutics Ltd Cambridge UK., Congreve M; Heptares Therapeutics Ltd Cambridge UK., Tasker T; Heptares Therapeutics Ltd Cambridge UK.
Publikováno v:
Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2022 Feb 23; Vol. 8 (1), pp. e12273. Date of Electronic Publication: 2022 Feb 23 (Print Publication: 2022).
Autor:
Brown AJH; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Bradley SJ; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK., Marshall FH; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Brown GA; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Bennett KA; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Brown J; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Cansfield JE; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Cross DM; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK; Cross Pharma Consulting Ltd, 20-22 Wenlock Road, London, N17GU, UK., de Graaf C; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Hudson BD; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Dwomoh L; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK., Dias JM; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Errey JC; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Hurrell E; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Liptrot J; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Mattedi G; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Molloy C; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK., Nathan PJ; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK; Brain Mapping Unit, University of Cambridge, Department of Psychiatry, Herchel Smith Building, Cambridge, CB20SZ, UK., Okrasa K; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Osborne G; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Patel JC; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Pickworth M; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Robertson N; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Shahabi S; Eli Lilly & Co, Neuroscience Discovery, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Bundgaard C; Eli Lilly & Co, Neuroscience Discovery, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK; H. Lundbeck A/S, Neuroscience Research, Ottiliavej 9, 2500 Valby, Copenhagen, Denmark., Phillips K; Eli Lilly & Co, Neuroscience Discovery, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Broad LM; Eli Lilly & Co, Neuroscience Discovery, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Goonawardena AV; Center for Neuroscience, Biosciences Division, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025, USA., Morairty SR; Center for Neuroscience, Biosciences Division, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025, USA., Browning M; University Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, OX12JD, UK; P1vital, Manor house, Howbery Buisness Park, Wallingford, OX108BA, UK., Perini F; Centre for Cognitive Neuroscience - Duke-NUS Medical School, 8 College Road, 169857, Singapore., Dawson GR; University Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, OX12JD, UK., Deakin JFW; Neuroscience and Psychiatry Unit, University of Manchester, Manchester, M139PT UK., Smith RT; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Sexton PM; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville 3052, Victoria, Australia; ARC Centre for Cryo-electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia., Warneck J; Protogenia Consulting Ltd, PO-Box 289, Ely, CB79DR, UK., Vinson M; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Tasker T; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Tehan BG; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Teobald B; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Christopoulos A; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville 3052, Victoria, Australia., Langmead CJ; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville 3052, Victoria, Australia., Jazayeri A; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Cooke RM; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Rucktooa P; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Congreve MS; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK., Weir M; Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK. Electronic address: malcolm.weir@soseiheptares.com., Tobin AB; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK. Electronic address: andrew.tobin@glasgow.ac.uk.
Publikováno v:
Cell [Cell] 2021 Nov 24; Vol. 184 (24), pp. 5886-5901.e22.
Autor:
Bakker C; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands., Prins S; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands., Liptrot J; Sosei Heptares, Cambridge, UK., Hart EP; Centre for Human Drug Research, Leiden, The Netherlands., Klaassen ES; Centre for Human Drug Research, Leiden, The Netherlands., Brown GA; Sosei Heptares, Cambridge, UK., Brown A; Sosei Heptares, Cambridge, UK., Congreve M; Sosei Heptares, Cambridge, UK., Weir M; Sosei Heptares, Cambridge, UK., Marshall FH; Sosei Heptares, Cambridge, UK.; MSD Research Laboratories (Merck & Co), Kenilworth, New Jersey, USA., Stevens J; Centre for Human Drug Research, Leiden, The Netherlands.; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Cross DM; Cross Pharma Consulting Ltd, Cambridge, UK., Tasker T; Sosei Heptares, Cambridge, UK., Nathan PJ; Sosei Heptares, Cambridge, UK.; Department of Psychiatry, University of Cambridge, Cambridge, UK.; School of Psychological Sciences, Monash University, Australia., Groeneveld GJ; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Nov; Vol. 87 (11), pp. 4439-4449. Date of Electronic Publication: 2021 May 08.